Jenny Bryant serves as executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA advocates for public policies that encourage the discovery of life-saving and life-enhancing new medicines for patients by biopharmaceutical research companies. Ms. Bryant leads PhRMA’s policy and research department in the development and implementation of legislative, regulatory and political strategies to successfully navigate the ever-changing federal health care landscape. In her prior role as senior vice president of policy and research, she oversaw the analysis and development of public policy related to health care costs and spending, prescription drug pricing and changes in health care delivery and payment.
Prior to joining PhRMA, Ms. Bryant was vice president at The Lewin Group, a national health care consulting firm. Previously, she held positions at Blue Cross Blue Shield Association, Blue Cross Blue Shield of Florida, New York Hospital-Cornell Medical Center and the State of New York.
Ms. Bryant graduated magna cum laude from Harvard College and received her MBA from the Harvard Graduate School of Business Administration.